期刊文献+

糖尿病并发急性胰腺炎38例临床分析 被引量:5

糖尿病并发急性胰腺炎38例临床分析
下载PDF
导出
摘要 目的:探讨探讨糖尿病并发急性胰腺炎的病因、诊断及治疗效果,提高临床诊治水平。方法:收治糖尿病并发急性胰腺炎患者38例,均检测随机血糖、血尿淀粉酶。及时给与胰岛素治疗和乌司他汀10万U,溶于10%葡萄糖250ml静滴,1次/12小时,奥曲肽治疗,0.6mg/24小时持续静滴,连用5~7天,根据临床需要,需要时进行手术治疗。结果:治疗前血糖12.33±6.88mmol/L,血淀粉酶1080±320U/L,尿淀粉酶2460±456U/L,治疗后血糖7.36±2.13mmol/L,血淀粉酶310±205U/L,尿淀粉酶550±320U/L,治疗前后比较差异有显著性(P<0.05)。结论:糖尿病并发急性胰腺炎死亡率高,时用胰岛素治疗,可以减少术后感染,减少术后死亡率。 Objective:To investigate the etiol- ogy, diagnosis, and treatment effects of dia- betes complicated by acute pancreatitis and improve the level of clinical diagnosis and treatment. Method:collected in our hospital from January 2010 to November 2012, the treatment of 38 patients with diabetes and a- cute pancreatitis patients, detect random blood sugar, urine amylase. Timely to give insulin therapy and ulinastat, 100000 U, was dissolved in 10% glucose 250ml intra- venous infusion, 1/12 hours, octreotide treat- ment, 0. 6mg/24 hour continuous intrave- nous infusion, once every 5 to 7 days, ac- cording to clinical need, the need for surgi- cal treatment. Results : Before treatment, blood glucose 12.33 ± 6.88retool/L, serum amylase 1080 ± 320U/L, urine amylase 2460 ± 456U/L after treatment, blood glu- cose 7.36 ± 2. 13mmol/L, serum amylase 310 ± 205U/L, urine amylase 550± 320u/ L, before and after treatment were significantdifferences( P 〈 O. 05 ). Conclusion : diabetes and acute pancreatitis high mortality when treated with insulin, can reduce postopera- tive infection, reduce postoperative mortali- ty.
作者 宋兴华
出处 《中国社区医师(医学专业)》 2013年第7期152-153,共2页
关键词 糖尿病 急性胰腺炎 diabetes acute pancreatitis
  • 相关文献

参考文献4

二级参考文献19

  • 1陈清棠 主编.临床神经病学[M].北京:北京科学技术出版社,2002.178.
  • 2KoizumiR,KanaiH,MaezawaA,et al.The rapeutic effects of ulinastatin on experiment alcrescentic glomerulone phritisinrats[J].N ephron,2000,84(4):347-531.
  • 3Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel Ⅲ). JAMA, 2001,285:2486-2497.
  • 4Lenzen M J, Boersma E, Bertrand ME, et al. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J, 2005,26: 1169- 1179. Epub 2005 Max 31.
  • 5Jenkins PJ, Harper RW, Nestel PJ. Severity of coronary atherosclerosis related to lipoprotein concentration. Br Med J, 1978,2:388-391.
  • 6Haffner SM, Kennedy E, Gonzalez C, et al. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care, 1996,19 : 1138-1141.
  • 7Ali Raza J, Movahed A. Current concepts of cardiovascular diseases in diabetes mellitus. Int J Cardiol, 2003,89 : 123-134.
  • 8Mak KH, Moliterno DJ, Granger CB, et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coil Cardiol, 1997,30 : 171-179.
  • 9Miettinen H, Lehto S, Salomaa V, et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care, 1998,21 : 69 -75.
  • 10Caracciolo EA, Chaitman BR, Forman SA, et al. Diabetics with coronary disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients. Circulation, 1996,93:2097-2105.

共引文献603

同被引文献19

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部